Zalicus Inc. (ZLCS) Reports Financial Results for the First Quarter 2013
5/2/2013 8:18:46 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today reported financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by